Company profile
Optieum Biotechnologies company profile
Optieum Biotechnologies Inc. is a pre-clinical stage biotechnology company committed to developing innovative scFv antibody-based therapies for the treatment of patients with cancers. Their proprietary platform technology, Eumbody System™, enables to develop and detect a scFv-based product candidates that specifically bind to, and modulate to optimize the immune-cell function for oncology targets. We are committed to helping patients with severe diseases by bringing life-changing therapies to the patients in need.
Business identity
- Website
- https://optieumbio.com
- Operating status
- Active
- Company type
- For Profit
- Employee range
- 1-10 employees
- Founded
- 2020-03-01
Headquarters
- Headquarters
- Matsuyama, Ehime, Japan
- Postal code
- 791-0204
- Country code
- JP
- Continent
- Asia